References
Yi X, Wu Y, Feng L, Huang J. Does viral hepatitis status relate to hepatocellular carcinoma after liver resection? Ann Surg Oncol. 2023. https://doi.org/10.1245/s10434-023-13724-9.
Rajendran L, Choi WJ, Muaddi H, et al. Association of viral hepatitis status and post-hepatectomy outcomes in the era of direct-acting antivirals. Ann Surg Oncol. 2023;30(5):2793–802. https://doi.org/10.1245/s10434-022-12937-8.
AASLD/IDSA HCV Guidance Panel. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62(3):932–54. https://doi.org/10.1002/hep.27950.
Lee CW, Tsai HI, Sung CM, et al. Risk factors for early mortality after hepatectomy for hepatocellular carcinoma. Medicine (Baltimore). 2016;95(39):e5028. https://doi.org/10.1097/MD.0000000000005028.
Dhir M, Samson KK, Yepuri N, Yanala UR, Smith LM, Are C. Preoperative nomogram to predict posthepatectomy liver failure. J Surg Oncol. 2021;123(8):1750–6. https://doi.org/10.1002/jso.26463.
Hoffmann K, Hinz U, Stravodimos C, et al. Risk assessment for liver resection. Surgery. 2018;164(5):998–1005. https://doi.org/10.1016/j.surg.2018.06.024.
Ye JZ, Mai RY, Guo WX, et al. Nomogram for prediction of the international study Group of Liver Surgery (ISGLS) grade B/C Posthepatectomy liver failure in HBV-related hepatocellular carcinoma patients: an external validation and prospective application study. BMC Cancer. 2020;20(1):1036. https://doi.org/10.1186/s12885-020-07480-2.
Kabir T, Syn NL, Tan ZZX, et al. Predictors of post-operative complications after surgical resection of hepatocellular carcinoma and their prognostic effects on outcome and survival: A propensity-score matched and structural equation modelling study. Eur J Surg Oncol. 2020;46(9):1756–65. https://doi.org/10.1016/j.ejso.2020.03.219.
Funding
No sources of funding were used to assist in the preparation of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Gonzalo Sapisochin discloses consultancy for Astra-Zeneca, Roche, Novartis, and Integra; has received financial compensation for talks for Roche, Astra-Zeneca, Chiesi, Evidera and Integra; and has received a grant from Roche. Luckshi Rajendran and Woo Jin Choi have no conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rajendran, L., Choi, W.J. & Sapisochin, G. Response to “Letter to the Editor: Does Viral Hepatitis Status Relate to Hepatocellular Carcinoma After Liver Resection?”. Ann Surg Oncol 30, 5455–5456 (2023). https://doi.org/10.1245/s10434-023-13732-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-023-13732-9